Science for People

IGEN BIOLAB GROUP brings microbiome science to the discovery and development of new therapeutic products.

About Us

Igen Biolab Group

Science for People

IGEN BIOLAB GROUP has established a pipeline of microbiome modulators in clinical phase development that impact in the prevention and treatment of diseases known to be linked at human microbiome dysfunction such as cancer, neurodegenerative and metabolic diseases.

IGEN BIOLAB GROUP R&D facilities include technical areas of In vitro cultivation and testing of microorganisms, mass spectrometry-based proteomics technologies to identify, characterize and quantify target proteins in various biological and biomedical samples, metabolomics for detection and quantification of small molecules (metabolites) in biological materials, microbiomics focusing on using molecular DNA microarray technology to address the complexities of human environmental microbiome ecology.

IGEN BIOLAB GROUP specializes in protein production, bacterial characterization and development of manufacturing processes that are optimized for robust high scale up production. IGEN BIOLAB GROUP commitment to medical progress goes hand in hand with our commitment towards our patients: everyone who might benefit from our findings must have the opportunity to do so. This promise is extended to physicians and the community of all those involved in patient care.

What are you waiting for?

IGEN BIOLAB, S.L.U, as Responsible of the Treatment will treat your personal data with the purpose of attending to the requests presented in the present form. You may exercise the rights established in Articles 15 to 22 of Regulation (EU) 2016/679, by sending an e-mail message to from the address provided in the register or as a means of contact.

2 + 2 =